000			01777 a2200469 4500
005			20250518023051.0
264		0	_c20200204
008			202002s 0 0 eng d
022			_a1469-5111
024	7		_a10.1093/ijnp/pyz010 _2doi
040			_aNLM _beng _cNLM
100	1		_aZorick, Todd
245	0	0	_aEffects of Citalopram on Cue-Induced Alcohol Craving and Thalamic D2/3 Dopamine Receptor Availability. _h[electronic resource]
260			_bThe international journal of neuropsychopharmacology _c04 2019
300			_a286-291 p. _bdigital
500			_aPublication Type: Controlled Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aAdministration, Intravenous
650	0	4	_aAdult
650	0	4	_aAlcoholism _xdrug therapy
650	0	4	_aBenzamides
650	0	4	_aCitalopram _xadministration & dosage
650	0	4	_aCorpus Striatum _xdrug effects
650	0	4	_aCraving _xdrug effects
650	0	4	_aCues
650	0	4	_aDouble-Blind Method
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPositron-Emission Tomography
650	0	4	_aPyrrolidines
650	0	4	_aReceptors, Dopamine D2 _xdrug effects
650	0	4	_aReceptors, Dopamine D3 _xdrug effects
650	0	4	_aSelective Serotonin Reuptake Inhibitors _xadministration & dosage
650	0	4	_aThalamus _xdrug effects
700	1		_aOkita, Kyoji
700	1		_aMandelkern, Mark A
700	1		_aLondon, Edythe D
700	1		_aBrody, Arthur L
773	0		_tThe international journal of neuropsychopharmacology _gvol. 22 _gno. 4 _gp. 286-291
856	4	0	_uhttps://doi.org/10.1093/ijnp/pyz010 _zAvailable from publisher's website
999			_c29362103 _d29362103